US 8895723
Methods of preparing substituted nucleotide analogs
granted A61PA61P31/12
Quick answer
US patent 8895723 (Methods of preparing substituted nucleotide analogs) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P31/12